marginally significantP = 0.072
13.37%, P = 0.0025) and a marginally significant increase in Tregs (FOXP + CD25 + CD4 + ) cells (0.86% vs. 5.11%, P = 0.072) in ITGAX -OE tumors than in the control tumors (Fig.
13.37%, P = 0.0025) and a marginally significant increase in Tregs (FOXP + CD25 + CD4 + ) cells (0.86% vs. 5.11%, P = 0.072) in ITGAX -OE tumors than in the control tumors (Fig.